Soban Umar

Has grant

Associate Professor

David Geffen School of Medicine at UCLA

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Soban Umar is an Associate Professor at the David Geffen School of Medicine at UCLA, specializing in pulmonary arterial hypertension and right heart failure research. His recent work includes exploring the connections between rat models and human pathobiology, transcriptomic analysis of right ventricular remodeling, and innovative approaches to address COVID-19 related challenges. He has also contributed to the field of medical education during the pandemic, focusing on anesthesiology trainees, and investigating the role of estrogen receptors in cardiovascular disease.

Recent Grants

Grant: Close

Role of the Novel MicroRNA-125b in Pulmonary Hypertension Associated with Pulmonary Fibrosis

Open Date: 2019-05-01

Close Date: 2024-04-30

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Andrea Frump

Assistant Professor

Indiana State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Soban Umar

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Recent advancements in pulmonary arterial hypertension and right heart failure research: overview of selected abstracts from ATS2020 and emerging COVID-19 research.

Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning.

Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.

A Novel Negative Pressure Isolation Device for Aerosol Transmissible COVID-19.

Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19.

In the eye of the storm: the right ventricle in COVID-19.

Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis.

Medical education in the COVID-19 era: Impact on anesthesiology trainees.

The Role of Estrogen Receptors in Cardiovascular Disease

Editorial Commentary: Pulmonary Artery Denervation for Pulmonary Hypertension: Recent Updates and Future Perspectives.

Collaborators (1)

Andrea Frump

Make your next move.